We need a dedicated framework that clarifies the rules, requirements and incentives for those building personalized ...

This paper introduces a pioneering approach integrating Advanced Encryption Standard (AES) security algorithms with multi-objective drug design, aimed at personalized medicine and optimized drug ...

With on demand medicine production at the point of care, it is now possible to tailor doses specifically to individual patients, allowing for more precise and personalised treatments with greater ease ...

3Division of Pharmaceutical Care Sciences, Graduate School of Pharmacy, Keio University, Minato-ku, Japan Objectives: The newest revision to the International Classification of Diseases, the 11 th ...

India’s top drug regulator is stepping in to change that. The Drug Controller General of India (DCGI) is working on a nationwide overhaul of medicine packaging and labelling norms.

China’s National Medical Products Administration (NMPA) has approved four new drugs developed by local biopharma companies, including a first-of-its-kind molecule in blood cancer. | Chinese ...

Pharmaceutical packaging is no longer just about containment and compliance—it’s about enabling patients, streamlining manufacturing, and accelerating time to market. In this Q&A, Mark Foster, General ...